The inhibition of DYRK1A is an enchanting therapeutic approach for the treatment of cognitive impairment in Down syndrome together with inhibiting tau hyperphosphorylation in Alzheimer’s disease [124]. Here, DYRK1A is linked to Cognitive impairment.